Kingworld Medicines Group (HKSE:01110) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01110 Kingworld Medicines Group Ltd HKSE:01110
43 GF Score
Price HK$0.48
GF Value HK$0.50
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Kingworld Medicines Group FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:01110
43GF Score
Kingworld Medicines Group Ltd HKSE:01110
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Kingworld Medicines Group (HKSE:01110) Overvalued in 2026?

Based on GuruFocus' analysis, Kingworld Medicines Group stock appears to be undervalued. The current stock price of HK$0.48 is trading 4% below its estimated GF Value™ of HK$0.50. GuruFocus considers Kingworld Medicines Group to be Fairly Valued.

Key valuation signals for HKSE:01110:

  • FFO:
  • GF Value™: HK$0.50 vs. price of HK$0.48 (4% below fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the HKSE:01110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kingworld Medicines Group Business Description

Address 198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in the Distribution of pharmaceutical and healthcare products, such as branded imported pharmaceutical and healthcare products in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices carried out in the PRC. It derives the majority of its revenue from the Distribution sales of the pharmaceutical and healthcare products segment.
43GF Score

Get the complete analysis for HKSE:01110

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.48
Price
HK$0.50
GF Value